What does it take to bring a cannabinoid pharmaceutical to market?
On Tuesday 23rd May Clare Foy (Global Market Access Director – Mtech Access) was joined by Michael Sassano (CEO – SOMAÍ Pharmaceuticals) for our first Global Whispers webinar. Michael shared with us his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons the Pharma industry can learn from their journey.
Listen to the podcast:
This episode is also available as a podcast. Listen below or search ‘Pharma Market Access Insights – from Mtech Access’ on Spotify, Apple Podcasts or Google Podcasts.
We are delighted to launch our new Global Whispers series, by welcoming Michael Sassano to share his experiences of bringing new products to market through both traditional and non-traditional reimbursement routes.
Michael is the Founder, Chairman and CEO of SOMAÍ Pharmaceuticals, a European Pharmaceutical and Biotech company that manufactures and distributes cannabinoid-containing pharmaceuticals throughout the EU.
In the webinar, Clare asked Michael about:
- Drug development and clinical trial processes for medical cannabis products
- Differences between the herbal medicines market and the Pharmaceutical market
- Overcoming regulatory and reimbursement challenges
- Finding the right place for cannabinoid medicines within existing pathways of care
- Perceptions, pathways and routes to access in different markets
- Lessons for the wider Pharma and Biotech industries
More about our speaker
Michael Sassano (CEO – SOMAÍ Pharmaceuticals)
Michael Sassano is one of the most respected executives in the pharmaceutical cannabis space today. He was an early investor in the cannabis industry in the United States; today he is celebrated in mainstream business and Biopharma media as an international authority on developing large-scale cannabis infrastructures throughout the world and the most advanced pharmaceutical cannabinoid products.
Michael is also widely respected for successfully predicting long term cannabis market trends and movements, which he generously shares in many forums. He is well known for leading a merger of the cannabis cultivation company he built and operated, called Solaris Farms, with The Sanctuary. Over the last few years, Michael has shifted focus to his role as CEO and Chairman of the Board for SOMAÍ Pharmaceuticals Ltd, a European pharmaceutical and biotech company centred on manufacturing in Lisbon, Portugal and distribution of EU GMP-certified cannabinoid-containing pharmaceuticals throughout EU.
We were delighted to welcome Michael to the Global Whispers webinar series.
The Global Whispers webinar series
This webinar is the first in our Global Whispers series. For over 2 years, Mtech Access have presented an industry-renowned NHS Whispers webinar series, where we interview experts from the UK healthcare system about the market landscape and the evolving challenges in the NHS. Following the success of this series, we are launching a new series looking at global market access challenges facing the Pharmaceutical and Medtech industries and offering insights into key launch markets. In June we will be looking at payment and access challenges for digital therapeutics and in July we will be focusing on market access challenges in the DACH region.
